This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Oncotherapy Science, Incorporated. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Michiko Harao: Innovator in Pharmaceutical Science
Introduction
Michiko Harao is a prominent inventor based in Kumamoto, Japan. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative peptides.
Latest Patents
Harao holds a patent for the "CDCA1 peptide and pharmaceutical agent comprising the same." This invention provides a peptide that can be utilized in various pharmaceutical applications, showcasing her expertise in biochemistry and drug development.
Career Highlights
Currently, Michiko Harao is associated with Oncotherapy Science, Incorporated, where she continues to advance her research and development efforts. Her work focuses on creating effective therapeutic agents that can improve patient outcomes.
Collaborations
Throughout her career, Harao has collaborated with notable colleagues, including Yasuharu Nishimura and Takuya Tsunoda. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.
Conclusion
Michiko Harao is a trailblazer in pharmaceutical innovation, with her work on the CDCA1 peptide exemplifying her commitment to advancing medical science. Her contributions continue to impact the industry positively.